Skip to main content
Clinical Trials/NL-OMON33175
NL-OMON33175
Recruiting
Phase 2

Safety and feasibility of the ketogenic diet in therapy resistand paediatric recurrent or progressive pontine glioma, a pilot study - Pontine glioma and ketogenic diet

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
10
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- recurrent or progressive pons glioma
  • \- 1\-18 years of age
  • \- failure of treatment with radiotherapy and Temozolomide and no therapeutic options left
  • \- good Dutch reading and writing (parents of caregivers)
  • \- Informed Consent of parents/care givers and/or the child (when \>12\)
  • \- willingness of children younger than 12 years to participate in the study

Exclusion Criteria

  • \- \< 1 year or \>17 year of age
  • \- use of Temozolomide or other chemotherapeutic drug
  • \- language barrier (parents or caregivers)
  • \- current treatment with steroids of treated within 3 weeks before start of the study
  • \- fatty acid disorders (like MCAD)
  • \- Hypertrigyceridemia (\> 10mmol/l)
  • \- kidney stones
  • \- diabetes mellitus
  • \- pancreatitis
  • \- gastro intestinal problems like persistent diarrhoea

Outcomes

Primary Outcomes

Not specified

Similar Trials